Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elizabeth Arden Inc Reaffirms FY 2013 Guidance


Thursday, 2 May 2013 07:00am EDT 

Elizabeth Arden Inc announced that based on the retail trends year-to-date and the seasonally slower fragrance market in the second fiscal half, the Company is reducing its revenue and earnings guidance. For fiscal 2013, the Company currently expects net sales to increase by 9% to 11%, assuming an expected unfavorable impact from foreign currency of approximately 0.5%, as compared to the prior year period, and for earnings per diluted share (adjusted) to be in the range of $2.30 to $2.50. The Company reported revenue of $1.238 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.36 billion and EPS of $2.41 for fiscal 2013. 

Company Quote

20.16
0.63 +3.23%
22 Dec 2014